[Advanced cancer of the ovary. Treatment and results]

Other public-domain-us
View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-08-09 ⓘ

Sixty-five advanced ovarian cancer patients treated with aggressive surgery, chemotherapy, and second-look surgery showed a 43% response rate and 12% fourth-year survival without recurrence.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The management of advanced ovarian carcinoma (stages IIb, III, IV) is presented together with the results of treating a series of 65 patients at Gustave-Roussy Institute. The response rate was 43 p. cent with 16 complete remissions and 12 partial remissions out of 65 patients. Fourth year survival without recurrences was 12/65; 9/16 after complete remission at 2nd look, and 3/12 after partial remission. Treatment was by surgery--chemotherapy--2nd look surgery; radiotherapy and/or chemotherapy are decided on after 2nd look surgery. Each treatment should be agressive, prolonged, and multi-disciplinary.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Adenocarcinoma Cystadenocarcinoma Endometriosis Ovarian Neoplasms Adenocarcinoma Adenocarcinoma Adenocarcinoma Aged Aged Combined Modality Therapy Combined Modality Therapy Cystadenocarcinoma Cystadenocarcinoma Cystadenocarcinoma Endometriosis Endometriosis Endometriosis Female Female Follow-Up Studies

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-18T09:30:06.152893+00:00
pubmed
last seen: 2026-10-08T21:39:52.685244+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine